These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 19176035)
1. [Effect on bcr-abl signaling pathway and the mechanisms of apoptosis induction by meisoindigo in K562 cells]. Liu BC; Xiao ZJ Zhonghua Xue Ye Xue Za Zhi; 2008 Dec; 29(12):815-8. PubMed ID: 19176035 [TBL] [Abstract][Full Text] [Related]
2. Induction of apoptosis by apicidin, a histone deacetylase inhibitor, via the activation of mitochondria-dependent caspase cascades in human Bcr-Abl-positive leukemia cells. Cheong JW; Chong SY; Kim JY; Eom JI; Jeung HK; Maeng HY; Lee ST; Min YH Clin Cancer Res; 2003 Oct; 9(13):5018-27. PubMed ID: 14581377 [TBL] [Abstract][Full Text] [Related]
3. [Inducement effect of Meisoindigo on apoptosis of leukemia cell line HL-60 and its mechanism]. Wang Y; Zhu XF; Xiao ZJ; Wang HH; Zhou JM; Mei YP; Deng R; Jiang WQ; Liu ZC Ai Zheng; 2005 Dec; 24(12):1464-8. PubMed ID: 16351793 [TBL] [Abstract][Full Text] [Related]
4. Cotreatment with apicidin overcomes TRAIL resistance via inhibition of Bcr-Abl signaling pathway in K562 leukemia cells. Park SJ; Kim MJ; Kim HB; Sohn HY; Bae JH; Kang CD; Kim SH Exp Cell Res; 2009 Jul; 315(11):1809-18. PubMed ID: 19268463 [TBL] [Abstract][Full Text] [Related]
5. Apoptotic effect of As2S2 on K562 cells and its mechanism. Li JE; Wu WL; Wang ZY; Sun GL Acta Pharmacol Sin; 2002 Nov; 23(11):991-6. PubMed ID: 12421474 [TBL] [Abstract][Full Text] [Related]
6. Disruption of the inhibitor of apoptosis protein survivin sensitizes Bcr-abl-positive cells to STI571-induced apoptosis. Wang Z; Sampath J; Fukuda S; Pelus LM Cancer Res; 2005 Sep; 65(18):8224-32. PubMed ID: 16166298 [TBL] [Abstract][Full Text] [Related]
7. [Synergism of As2S2 and STI 571 in inducing apoptosis of K562 cells]. Li JE; Sun GL; Wu YL; Wu WL Zhonghua Xue Ye Xue Za Zhi; 2003 Nov; 24(11):580-3. PubMed ID: 14720443 [TBL] [Abstract][Full Text] [Related]
8. Flavopiridol potentiates STI571-induced mitochondrial damage and apoptosis in BCR-ABL-positive human leukemia cells. Yu C; Krystal G; Dent P; Grant S Clin Cancer Res; 2002 Sep; 8(9):2976-84. PubMed ID: 12231544 [TBL] [Abstract][Full Text] [Related]
9. E1A overcomes the apoptosis block in BCR-ABL+ leukemia cells and renders cells susceptible to induction of apoptosis by chemotherapeutic agents. Stiewe T; Parssanedjad K; Esche H; Opalka B; Pützer BM Cancer Res; 2000 Jul; 60(14):3957-64. PubMed ID: 10919674 [TBL] [Abstract][Full Text] [Related]
10. Immunoreactivity of Stat5 phosphorylated on tyrosine as a cell-based measure of Bcr/Abl kinase activity. Jacobberger JW; Sramkoski RM; Frisa PS; Ye PP; Gottlieb MA; Hedley DW; Shankey TV; Smith BL; Paniagua M; Goolsby CL Cytometry A; 2003 Aug; 54(2):75-88. PubMed ID: 12879454 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of Bcr-Abl kinase activity by PD180970 blocks constitutive activation of Stat5 and growth of CML cells. Huang M; Dorsey JF; Epling-Burnette PK; Nimmanapalli R; Landowski TH; Mora LB; Niu G; Sinibaldi D; Bai F; Kraker A; Yu H; Moscinski L; Wei S; Djeu J; Dalton WS; Bhalla K; Loughran TP; Wu J; Jove R Oncogene; 2002 Dec; 21(57):8804-16. PubMed ID: 12483533 [TBL] [Abstract][Full Text] [Related]
12. Differences in BCL-X(L) expression and STAT5 phosphorylation in chronic myeloid leukaemia patients. Gutiérrez-Castellanos S; Cruz M; Rabelo L; Godínez R; Reyes-Maldonado E; Riebeling-Navarro C Eur J Haematol; 2004 Apr; 72(4):231-8. PubMed ID: 15089759 [TBL] [Abstract][Full Text] [Related]
13. Selective pyrrolo-pyrimidine inhibitors reveal a necessary role for Src family kinases in Bcr-Abl signal transduction and oncogenesis. Wilson MB; Schreiner SJ; Choi HJ; Kamens J; Smithgall TE Oncogene; 2002 Nov; 21(53):8075-88. PubMed ID: 12444544 [TBL] [Abstract][Full Text] [Related]
14. The multikinase inhibitor sorafenib induces apoptosis in highly imatinib mesylate-resistant bcr/abl+ human leukemia cells in association with signal transducer and activator of transcription 5 inhibition and myeloid cell leukemia-1 down-regulation. Rahmani M; Nguyen TK; Dent P; Grant S Mol Pharmacol; 2007 Sep; 72(3):788-95. PubMed ID: 17595328 [TBL] [Abstract][Full Text] [Related]
15. Triptolide inhibits Bcr-Abl transcription and induces apoptosis in STI571-resistant chronic myelogenous leukemia cells harboring T315I mutation. Shi X; Jin Y; Cheng C; Zhang H; Zou W; Zheng Q; Lu Z; Chen Q; Lai Y; Pan J Clin Cancer Res; 2009 Mar; 15(5):1686-97. PubMed ID: 19240172 [TBL] [Abstract][Full Text] [Related]
16. Cooperative and redundant effects of STAT5 and Ras signaling in BCR/ABL transformed hematopoietic cells. Hoover RR; Gerlach MJ; Koh EY; Daley GQ Oncogene; 2001 Sep; 20(41):5826-35. PubMed ID: 11593388 [TBL] [Abstract][Full Text] [Related]
17. [Effect of specific siRNA targeting against bcr-abl chimeric gene on chronic myelogenous leukemia cells]. Wang S; Chai YB; Liu F; Zhang XY; Jia W; Xie X; Yu WQ; Shang ZC; Jin BQ; Sun BZ Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(3):198-202. PubMed ID: 15854468 [TBL] [Abstract][Full Text] [Related]
18. N-Benzyladriamycin-14-valerate (AD 198) cytotoxicty circumvents Bcr-Abl anti-apoptotic signaling in human leukemia cells and also potentiates imatinib cytotoxicity. Lothstein L; Savranskaya L; Sweatman TW Leuk Res; 2007 Aug; 31(8):1085-95. PubMed ID: 17187856 [TBL] [Abstract][Full Text] [Related]
19. [Effect of hydroxyurea combined with interferon-alpha on growth and apoptosis-related oncogene expression of K562 cells]. Chen H; Luo Z; Luo S Zhonghua Yi Xue Za Zhi; 2000 Aug; 80(8):606-9. PubMed ID: 11798827 [TBL] [Abstract][Full Text] [Related]
20. The mechanism of STI571 inducing apoptosis of K562 cells. Qin Y; Chen S; Chang Y; Fu J; Wang X Zhonghua Xue Ye Xue Za Zhi; 2002 Jun; 23(6):289-92. PubMed ID: 12411057 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]